These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 307266)
1. [Inter-alpha-trypsin inhibitor in serum and bronchial mucus inhibitor in sputum in chronic airway obstruction (author's transl)]. Rasche B; Hochstrasser K; Ulmer WT Respiration; 1978; 36(1):39-47. PubMed ID: 307266 [No Abstract] [Full Text] [Related]
2. [Free and combined protease inhibitors in bronchial mucus in patients with extended chronic obstructive airway diseases (author's transl)]. Hochstrasser K; Rasche B; Reichert R; Hochgesand K Pneumonologie; 1974; 150(2-4):253-9. PubMed ID: 4419015 [No Abstract] [Full Text] [Related]
3. [Protease and antiprotease activity in sputum and broncho-alveolar smears in healthy subjects and in inflammatory diseases of the lungs]. Bogadel'nikov IV; Protsenko VA; Egorychev VE; Gorishniak LKh Pediatriia; 1985 Jul; (7):74-7. PubMed ID: 2413421 [No Abstract] [Full Text] [Related]
4. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome]. Rasche B; Hochstrasser K; Marcic I; Ulmer WT Respiration; 1975; 32(5):340-54. PubMed ID: 1080869 [TBL] [Abstract][Full Text] [Related]
5. [Proteolytic enzymes and their inhibitors in bronchopulmonary diseases (a review of the literature)]. Veremeenko KN; Kizim AI Vrach Delo; 1985 Jul; (7):34-8. PubMed ID: 3901514 [No Abstract] [Full Text] [Related]
6. [Elastase and elastase inhibitors in bronchial mucus in chronic airway obstruction with reference to therapy]. Rasche B; Hochstrasser K Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():725-7. PubMed ID: 6557570 [No Abstract] [Full Text] [Related]
7. [About the question of simultaneously occuring proteolytic and antiproteolytic activity in sputum in case of obstructive airway diseases (author's transl)]. Hochstrasser K; Hochgesand K; Rasche B Respiration; 1974; 31(4):343-9. PubMed ID: 4842829 [No Abstract] [Full Text] [Related]
8. [Proteases and their inhibitors in the pathogenesis of pulmonary emphysema]. Tishkin OG Arkh Patol; 1979; 41(3):66-70. PubMed ID: 311629 [No Abstract] [Full Text] [Related]
9. [Possibilities for inactivation of protease activity in sputum by protease inhibitors in chronic obstructive airway diseases]. Rasche B; Ulmer WT Res Exp Med (Berl); 1972; 158(3):229-45. PubMed ID: 4117560 [No Abstract] [Full Text] [Related]
10. [Inhibitors of proteases in bronchial secretion of patients deficient in alpha-l-antitrypsin]. Laine A; Lebas J; Hayem A Lille Med; 1976 Feb; 21(2):140-3. PubMed ID: 1084948 [No Abstract] [Full Text] [Related]
11. Inhibitor activity against elastolytic enzymes in the bronchial area. A contribution to the pathogenesis of chronic airway obstruction. Rasche B Z Erkr Atmungsorgane; 1985; 165(1):83-93. PubMed ID: 3851611 [TBL] [Abstract][Full Text] [Related]
12. [Introduction to a study of the hydrosoluble proteins of the sputum (author's transl)]. Scrobogna S; Trani S; Predominato M; Novello E Ann Sclavo; 1976; 18(2):357-63. PubMed ID: 1087870 [TBL] [Abstract][Full Text] [Related]
13. Proteases and protease inhibitors in chronic obstructive lung disease. Erikson S Acta Med Scand; 1978; 203(6):449-55. PubMed ID: 78661 [No Abstract] [Full Text] [Related]
14. [Antiproteolytic potential of the blood serum in chronic nonspecific lung diseases]. Kaminskaia GO; Zhukova NL; Ozerova LB Sov Med; 1986; (10):77-81. PubMed ID: 2433771 [No Abstract] [Full Text] [Related]
15. The biochemical pathogenesis of chronic obstructive pulmonary diseases: protease-antiprotease imbalance in emphysema and diseases of the airways. Kuhn C J Thorac Imaging; 1986 Mar; 1(2):1-6. PubMed ID: 3298671 [TBL] [Abstract][Full Text] [Related]
16. [Arterial blood gas tensions and airways obstruction in normal subjects and patients with obstructive lung disease before and during adaptation to altitude (author's transl)]. Hartmann B; Unger M; Debelić M; Hilpert P Respiration; 1974 Jan; 31(1):7-20. PubMed ID: 4810262 [No Abstract] [Full Text] [Related]
17. [The protease-inhibitor capacity of human bronchial mucus. Content in low molecular inhibitor and 1 -antitrypsin under physiological and physiopathological conditions]. Reichert R; Hochstrasser K; Conradi G Pneumonologie; 1972; 147(1):13-20. PubMed ID: 5083256 [No Abstract] [Full Text] [Related]
18. [The change concentrations in the serum of immunoglobulins and alpha-1 atitrypsin in children with obstructive pulmonary diseases]. Miljković D; Dzelebcjić J; Kostić N Srp Arh Celok Lek; 1995; 123(5-6):116-9. PubMed ID: 17974450 [TBL] [Abstract][Full Text] [Related]
19. [Pathophysiology of chronic, bronchial hypersecretion (author's transl)]. Puchelle E; Girard F; Polu JM; Aug F; Sadoul P Pathol Biol (Paris); 1978 Oct; 26(7):441-51. PubMed ID: 372900 [TBL] [Abstract][Full Text] [Related]